BioCardia Inc

Research BioCardia Inc (BCDA) on Bullrun: market cap USD 13.76M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerBCDA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 13.76M
• Financial periodFY2025
• Revenue growth-100.0%
• Net income-USD 8.23M
• Free cash flow-USD 7.44M

Valuation Snapshot

latest market cap is USD 13.76M.

About BioCardia Inc

BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. The company's lead product candidate is CardiAMP, an autologous mononuclear cell therapy system in Phase III clinical trial for the treatment of ischemic heart failure with reduced ejection fraction and refractory angina resulting from chronic myocardial ischemia.

Frequently asked questions

What is BioCardia Inc's market cap?

BioCardia Inc's market capitalization is USD 13.76M.

What does BioCardia Inc do?

BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States.